Macrophage Redox State in Sterilizing and Injurious Inflammation
Macrophage Redox State in Sterilizing and Injurious Inflammation
批准号:
9894728
负责人:
Marcelo G Bonini
金额:
$42.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-07 至 2022-03-31
关键词:
AcuteAcute Lung InjuryAddressAdult Respiratory Distress SyndromeAffectAlveolarAnti-Inflammatory AgentsBacterial ModelBacterial PneumoniaBiochemical ProcessCISH geneCell NucleusComplexCre driverCritical IllnessCysteineDevelopmentDiffuseEndotheliumEnzymesGene ExpressionGenesGenetic TranscriptionGenetically Engineered MouseHypoxiaImmuneInflammationInflammatoryInnate Immune ResponseLeadLifeLungLung InflammationMediatingModificationMolecularMusMyeloid CellsNatural ImmunityNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type INuclearOutcomeOutputOxidation-ReductionPhenotypePlayPopulationPrevalencePseudomonas aeruginosaPublishingPulmonary InflammationReactive Oxygen SpeciesResolutionRespiratory FailureRoleSWI1Signal TransductionSterilityStructure of parenchyma of lungTNFRSF5 geneTestingTissuesTranscription Factor 3basecell typehealingintravital microscopylung injurymacrophagemortalitymouse modelneutrophilnovelnovel therapeutic interventionoxidationp65pathogenpreservationpreventresponsesurfactant productiontissue injurytranscription factortwo-photon
中文摘要
目前的项目集中在研究先天免疫极化的基本机制。
回应。巨噬细胞是导致先天免疫极化的主要细胞类型。
通过启动和传播炎症(M1表型)或通过消炎促进
组织愈合(M2表型)。一个相对新的观点是巨噬细胞极化的失调
随着M1的流行超过M2的流行,表型促进了广泛的炎症和急性组织
受伤。在肺部的情况下,急性肺损伤(ALI)可能演变为急性呼吸窘迫综合征
(ARDS),一种高度致命的呼吸衰竭形式。因此,了解
巨噬细胞极化为功能不同的表型可能导致新的治疗策略
预防或治疗ARDS。核因子κB(核因子κB)是炎症反应的主要调节因子
负责促进或消除炎症的基因的表达。而p65/p50
核因子κB的配置促进炎症,p50/p50配置促进分辨率。我们
原因是这些配置也调节巨噬细胞如何极化成不同的表型。在……里面
在这方面,我们最近发现,细胞因子信号转导抑制因子-1(SOCS1)可能作用于
切换到NFκB功能,因为它针对的是核p65而不是p50,以降解为目标改变相对
核内这些组成亚基的丰度。SOCS1对此敏感的发现
一氧化氮(NO)和可能的其他活性物种的抑制也表明了新的分子
SOCS1活性、核因子κB功能、促炎和抗炎转录的机制
巨噬细胞极化和炎症结果受到调控。这些机制是
我们提出的三个目标的重点:(1)确定SOCS1促进NFκB的机制
从前转录复合体到抗炎转录复合体的功能转换;
确定巨噬细胞细胞内氧化还原状态的变化是否影响SOCS1活性和核因子κB
作为转录因子发挥作用和(3)决定SOCS1在不同免疫细胞中的表达
TYPE调节小鼠模型炎症扩散和消退之间的转换
细菌性肺炎。
英文摘要
The current project is focused on the study of basic mechanisms of polarization of the innate immune
response. Macrophages are the primary cell type responsible for the polarization of the innate immunity
either by initiating and propagating inflammation (M1 phenotype) or resolving inflammation to promote
tissue healing (M2 phenotype). A relative new idea is that the dysregulation of macrophage polarization
with the prevalence of M1 over M2 phenotype promotes wide-spread inflammation and acute tissue
injury. In the case of lungs acute lung injury (ALI) may evolve to acute respiratory distress syndrome
(ARDS), a highly lethal form of respiratory failure. Hence, understanding the mechanisms by which
macrophages polarize into functionally distinct phenotypes may lead to new therapeutic strategies to
prevent or treat ARDS. Nuclear factor κB (NFκB) is a master regulator of inflammation being
responsible for the expression of genes that promote or resolve inflammation. While the p65/p50
configuration of NFκB promotes inflammation, the p50/p50 configuration promotes resolution. We
reason that these configurations also regulate how macrophages polarize into distinct phenotypes. In
this regard, we recently discovered that suppressor of cytokine signaling-1 (SOCS1) may operate the
switch in NFκB function since it targets nuclear p65 but not p50 to degradation changing the relative
abundances of these component subunits in the nucleus. The finding that SOCS1 is sensitive to
inhibition by nitric oxide (NO) and possibly other reactive species also indicate novel molecular
mechanisms by which SOCS1 activity, NFκB function, pro- and anti-inflammatory transcription, as well
as macrophage polarization and inflammatory outcomes are regulated. These mechanisms are the
focus of our three proposed aims: (1) to determine the mechanism by which SOCS1 promotes NFκB
functional switch from that of a pro- to that of an anti-inflammatory transcriptional complex; (2) to
determine if changes in the intracellular redox state of macrophages affects SOCS1 activity and NFκB
function as a transcription factor and (3) Determine how SOCS1 expression in different immune cell
types regulates the transition between inflammation propagation and resolution in a mouse model of
bacterial pneumonia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Arsenic suppresses progesterone receptor signaling and promotes tamoxifen resistance and metastasis of ER+ breast cancer
-
批准号:10662054
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2022
-
负责人:Marcelo G Bonini
-
依托单位:
A redox-sensitive switch in the macrophage nucleus regulates acute phase inflammatory injury
-
批准号:10451112
-
项目类别:
-
资助金额:$57.08万
-
财政年份:2022
-
负责人:Marcelo G Bonini
-
依托单位:
A redox-sensitive switch in the macrophage nucleus regulates acute phase inflammatory injury
-
批准号:10631088
-
项目类别:
-
资助金额:$55.58万
-
财政年份:2022
-
负责人:Marcelo G Bonini
-
依托单位:
Environmental Arsenic in the Subtype Specification of Breast Cancer
-
批准号:10252934
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2020
-
负责人:Marcelo G Bonini
-
依托单位:
Environmental Arsenic in the Subtype Specification of Breast Cancer
-
批准号:10488608
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2020
-
负责人:Marcelo G Bonini
-
依托单位:
Environmental Arsenic in the Subtype Specification of Breast Cancer
-
批准号:10204605
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2020
-
负责人:Marcelo G Bonini
-
依托单位:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
-
批准号:10221632
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2018
-
负责人:Marcelo G Bonini
-
依托单位:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
-
批准号:10193167
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2018
-
负责人:Marcelo G Bonini
-
依托单位:
MnSOD Acetylation Promotes Cancer Stem Cell Phenotypes in Breast Cancer
-
批准号:9763487
-
项目类别:
-
资助金额:$34.17万
-
财政年份:2018
-
负责人:Marcelo G Bonini
-
依托单位:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
-
批准号:10380372
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2018
-
负责人:Marcelo G Bonini
-
依托单位:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
-
批准号:10453720
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2018
-
负责人:Marcelo G Bonini
-
依托单位:
Macrophage Redox State in Sterilizing and Injurious Inflammation
-
批准号:10226837
-
项目类别:
-
资助金额:$41.82万
-
财政年份:2017
-
负责人:Marcelo G Bonini
-
依托单位:
New strategies for treating septic vasculopathy, inflammation and thrombosis
-
批准号:8927682
-
项目类别:
-
资助金额:$63.78万
-
财政年份:2014
-
负责人:Marcelo G Bonini
-
依托单位:
New strategies for treating septic vasculopathy, inflammation and thrombosis
-
批准号:9069974
-
项目类别:
-
资助金额:$64.76万
-
财政年份:2014
-
负责人:Marcelo G Bonini
-
依托单位:
New strategies for treating septic vasculopathy, inflammation and thrombosis
-
批准号:8803056
-
项目类别:
-
资助金额:$64.76万
-
财政年份:2014
-
负责人:Marcelo G Bonini
-
依托单位:
Oxidative stress imbalance n Pulmonary&Cardiovascular disease,Electron paramagnet
-
批准号:8052669
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2011
-
负责人:Marcelo G Bonini
-
依托单位:
Cancer Research Career Enhancement andRelated Activities
-
批准号:10460183
-
项目类别:
-
资助金额:$24.16万
-
财政年份:1997
-
负责人:Marcelo G Bonini
-
依托单位:
Cancer Research Career Enhancement andRelated Activities
-
批准号:10228185
-
项目类别:
-
资助金额:$24.16万
-
财政年份:1997
-
负责人:Marcelo G Bonini
-
依托单位:
Cancer Research Career Enhancement andRelated Activities
-
批准号:10902175
-
项目类别:
-
资助金额:$21.67万
-
财政年份:1997
-
负责人:Marcelo G Bonini
-
依托单位:
海外基金